Pfizer Inc. buy BMO Capital Markets
Start price
02.08.23
/
50%
€32.40
Target price
02.08.24
€40.22
Performance (%)
-15.59%
End price
03.08.24
€27.35
Summary
This prediction ended on 03.08.24 with a price of €27.35. The price of Pfizer Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.59%. BMO_Capital_Markets has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Dividends of €1.93 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Pfizer Inc. | 5.208% | 5.208% | 10.557% | -28.650% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% | 62.632% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% | 85.627% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% | 76.252% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% | 69.873% |
Comments by BMO_Capital_Markets for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at BMO Capital Markets from $45.00 to $44.00. They now have an "outperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten